Risk of stroke in patients unresponsive til antiplatelet therapy

Risk of apoplexia cerebri in clopidogrel non-responders. - Risk of apoplexia cerebri in clopidogrel non-responders.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-004748-23-DK

Enrollment

Unknown

Registered

2011-10-28

Start date

2011-12-05

Completion date

Unknown

Last updated

2016-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apoplexia cerebri

Interventions

Trade Name: Clopidogrel ”Actavis” Product Name: Clopidogrel Product Code: 26181 Pharmaceutical Form: INN or Proposed INN: CLOPIDOGREL CAS Number: 113665-84-2 Concentration unit: mg milligram(s) Conce

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patientens with first-time ischemic apoplexia cerebri who recieves clopidogrel Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 150 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 150

Exclusion criteria

Exclusion criteria: haemorrhagic stroke Known cancer other antiplatelet therapy treatment

Design outcomes

Primary

Measure	Time frame
Main Objective: Assesment of risk og apoplexia cerebri in clopidogrel non-responders;Secondary Objective: risk of vascular death or heart attack;Primary end point(s): vascular death acute myocardial infarction stroke;Timepoint(s) of evaluation of this end point: two years follow-up	—

Secondary

Measure	Time frame
Secondary end point(s): age, sex, race, BMI, Diabetes mellitus, hypertension, smoking, hemoglobin, cholesterole, previous AMI, other medications, compliance, living alone, cause of death;Timepoint(s) of evaluation of this end point: two years	—

Countries

Denmark

Contacts

Public ContactNeurologisk ambulatorium

Neurologisk Afdeling

clra@regionsjaelland.dk004547322800

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026